Chris Lau
Chris Lau (RSS)
InvestorPlace Contributor

Read complete bio
Recent Articles

GlaxoSmithKline Is More Than Just a 5% Dividend Income Play

Jul. 17, 2018, 12:33 pm EDT – GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock. More 

Aurinia Pharmaceuticals Has Lots of Upside Potential

Jul. 13, 2018, 10:36 am EDT – Aurinia is a biotech firm whose primary goal is treating Lupus. The company has plenty of cash for R&D. And that effort will pay off. More 

5 Big Pharma Stocks Investors Love Right Now

Jul. 13, 2018, 9:47 am EDT – The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd. More 

In the Case of Oracle Stock, Boring Does Not Equal Bad

Jul. 12, 2018, 10:20 am EDT – Oracle is hardly a hot stock that technology investors would pay much attention to these days -but investors are ignoring ORCL stock's deep discount to fair value. More 

Why AMD Stock Will Rally Before Its Earnings Announcement

Jul. 11, 2018, 11:58 pm EDT – AMD stock often moves big ahead of its quarterly earnings report. This time is no different, except markets are more volatile. More 

5 Pharmaceutical and Biotech Stocks to Consider for July

Jul. 6, 2018, 10:56 am EDT – Pfizer renewed the drug price hike cycle after it raised them for around 40 products. If other biotech stocks follow, profits will soar. More 

Alimera Stock Grew 25 Percent and It Is Just Getting Warmed Up

Jul. 5, 2018, 9:10 am EDT – Alimera is a risky penny stock with upside potential, provided management continues reporting quarterly revenue growth. For now, then, Alimera stock looks like a buy. More 

5 Hot Marijuana Stocks as Beer Companies Shop for an Acquisition

Jun. 26, 2018, 3:40 pm EDT – After taking a pause in its uptrend, marijuana stocks could get a lift again as Molson Coors shops for companies in this sector. Though the sector has yet to prove it is profitable, a buyout will lift nearly all marijuana stocks. More 

Why Tandem Stock Could Continue Its Rally

Jun. 25, 2018, 12:43 pm EDT – Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside. More 

Why Gevo, Inc. Stock Soared 262% Yesterday

Jun. 19, 2018, 10:35 am EDT – Gevo jumped a mouth-watering 261.82% in a single day. However, looking more closely in the company shows that investors will need to exercise caution. More